Anti-diabetic treatment regulates pro-fibrotic TGF-β serum levels in type 2 diabetics

BACKGROUND: The single-center, open-label, four-arm, exploratory study investigates the relation of different anti-diabetics to serum levels of active TGF-β, a known pro-fibrotic stimulus, before and after a defined test meal. FINDINGS: We investigated sera of patients with type 2 diabetes mellitus...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pscherer, Stefan, Freude, Thomas, Forst, Thomas, Nussler, Andreas K, Braun, Karl F, Ehnert, Sabrina
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3847073/
https://ncbi.nlm.nih.gov/pubmed/24004910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-5-48
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares